A study to evaluate whether the results of second line sunitinib therapy related to duration of response of first line imatinib in patients with advanced gastrointestinal stromal tumors (GIST).
Phase of Trial: Phase II
Latest Information Update: 04 Sep 2015
At a glance
- Drugs Sunitinib (Primary) ; Imatinib
- Indications Gastrointestinal stromal tumours
- Focus Therapeutic Use
- 04 Sep 2015 Status changed from not stated to completed.
- 20 Jul 2015 New trial record
- 02 Jun 2015 Results presented at the 51st Annual Meeting of the American Society of Clinical Oncology.